Shareholder Alert: Ademi LLP investigates whether Better Choice Company Inc. has obtained a Fair Price for its Public Shareholders

MILWAUKEE, Sept. 5, 2024 /PRNewswire/ -- Ademi LLP is investigating Better Choice (NYSE American: BTTR) for possible breaches of fiduciary duty and other violations of law in its transaction with SRx Health.

Click here to learn how to join our investigation https://www.ademilaw.com/case/better-choice-company-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Better Choice will engage in a reverse merger with SRx Health, with Better Choice owning approximately 15% of the combined company, on a fully diluted basis. The transaction agreement unreasonably limits competing transactions for Better Choice by imposing a significant penalty if Better Choice accepts a competing bid. Better Choice insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Better Choice's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Better Choice common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/better-choice-company-inc.                  

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                   
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

SOURCE Ademi LLP